No studies have examined the role of NRF2 in the effects of glucocorticoids regarding diabetes and osteoporosis, and the few relevant prior studies that employed rodents treated with glucocorticoids used only male mice and were mostly focused on other outcomes than glucose metabolism and osteoporosis. This evidence concerns the gene NFE2L2 and diabetes mellitus.